Note: Ingredients listed on restricted chemical lists
EC/CAS
1305-78-8
Name of the chemical
Calcium oxide
Concentration
N/A
General Information
Revision date
2021-05-05
Product name
Calbux, Biocal, Limbase
Substance name
Calcium Oxide
Product Synonyms
LIME & POWDERS
Chemical name
Calcium Oxide - CaO
CAS No.
1305-78-8
REACH No
01-2119475325-36-0121
Icons in SDS
Company Information
company name
Tarmac Cement & Lime
e-mail address of the competent person responsible for the Safety Data Sheet
buxton.enquiry@tarmac.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H318, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
2.1 Classification of the substance or mixture
2.1.1
CLP CLASSIFICATION
STOT Single Exp. 3, H335 Route of exposure: Inhalation Skin Irritation 2, H315 Eye Damage 1, H318 2.1.2
Additional information
For full text of H-statements and P-phrases; see SECTION 16
2.2 Label elements
2.2.1 Labelling according to Regulation (EC) 1272/2008
Signal word
Danger
Hazard statements
H315: Causes skin irritation H318: Causes serious eye damage H335: May cause respiratory irritation
Precautionary statements
P102: Keep out of reach of children P280: Wear protective gloves/protective clothing/eye protection/face protection P305+P351+P338: If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302+P352: IF ON SKIN: Wash with plenty of water P310: Immediately call a POISON CENTRE or doctor/physician P261: Avoid breathing dust/spray P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing P501: Dispose of contents/container in accordance with local/regional/national/international regulation
2.3 Other hazards
No other hazards identified. The substance does not meet the criteria for PBT or vPvB substance according to Regulation (EC) No 1907/2006, Annex XIII. The substance is not included in the Candidate List of substances of very high concern for Authorisation. The substance is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
